Roberto F P Machado

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Sildenafil in the treatment of pulmonary hypertension
    Christopher F Barnett
    Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA
    Vasc Health Risk Manag 2:411-22. 2006
  2. ncbi request reprint Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension
    Roberto F Machado
    Vascular Therapeutics Section, Cardiovascular Branch, National Heart Lung and Blood Institute and Critical Care Medicine Department, Clinical Center, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892, USA
    Br J Haematol 129:449-64. 2005
  3. pmc Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension
    Roberto F Machado
    Vascular Therapeutics Section, Cardiovascular Branch, National Heart Lung and Blood Institute, Bethesda, MD, USA
    Br J Haematol 130:445-53. 2005
  4. ncbi request reprint N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease
    Roberto F Machado
    Vascular Medicine Branch, Clinical Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892 1454, USA
    JAMA 296:310-8. 2006
  5. pmc Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease
    Roberto F Machado
    Vascular Medicine Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892 1476, USA
    Br J Haematol 136:319-25. 2007
  6. ncbi request reprint Sickle cell anemia-associated pulmonary arterial hypertension
    Roberto F P Machado
    National Institutes of Health, Bethesda, MD 20892 1476, USA
    J Bras Pneumol 33:583-91. 2007
  7. ncbi request reprint Pulmonary hypertension in chronic respiratory disorders: we need to learn more
    Roberto F P Machado
    J Bras Pneumol 34:65-6. 2008

Detail Information

Publications7

  1. pmc Sildenafil in the treatment of pulmonary hypertension
    Christopher F Barnett
    Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA
    Vasc Health Risk Manag 2:411-22. 2006
    ..The oral formulation and favorable adverse effect profile make sildenafil an attractive alternative in the treatment of selected patients with pulmonary hypertension...
  2. ncbi request reprint Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension
    Roberto F Machado
    Vascular Therapeutics Section, Cardiovascular Branch, National Heart Lung and Blood Institute and Critical Care Medicine Department, Clinical Center, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892, USA
    Br J Haematol 129:449-64. 2005
    ..A large trial evaluating the effects of therapy for pulmonary hypertension in the SCD population is clearly indicated...
  3. pmc Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension
    Roberto F Machado
    Vascular Therapeutics Section, Cardiovascular Branch, National Heart Lung and Blood Institute, Bethesda, MD, USA
    Br J Haematol 130:445-53. 2005
    ....
  4. ncbi request reprint N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease
    Roberto F Machado
    Vascular Medicine Branch, Clinical Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892 1454, USA
    JAMA 296:310-8. 2006
    ..Levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) provide such information in patients with idiopathic pulmonary arterial hypertension...
  5. pmc Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease
    Roberto F Machado
    Vascular Medicine Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892 1476, USA
    Br J Haematol 136:319-25. 2007
    ..001) in all subjects. These data suggest that acute elevations in pulmonary pressures during VOC or exercise may contribute to morbidity and mortality in patients with sickle cell disease...
  6. ncbi request reprint Sickle cell anemia-associated pulmonary arterial hypertension
    Roberto F P Machado
    National Institutes of Health, Bethesda, MD 20892 1476, USA
    J Bras Pneumol 33:583-91. 2007
    ..Large trials evaluating the effects of treatment for pulmonary hypertension in the sickle cell anemia population are underway...
  7. ncbi request reprint Pulmonary hypertension in chronic respiratory disorders: we need to learn more
    Roberto F P Machado
    J Bras Pneumol 34:65-6. 2008